Systemic Treatment of Colorectal CancerBrian M. Wolpin(Harvard University), Robert J. Mayer(Harvard University)GastroenterologyMay 1, 200810.1053/j.gastro.2008.02.098Cited by 506Open AccessFull TextSaveCiteExport RISWatch citationsAbstractRelated PapersComparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III StudyPaulo M. Hoff, Rafat Ansari, Gerald Batist et al.|Journal of Clinical Oncology|2001|1.1kRandomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.Aimery de Gramont, J.-F. Bosset, C Milan et al.|Journal of Clinical Oncology|1997|905Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Michael A. Poon, M. J. OʼConnell, C G Moertel et al.|Journal of Clinical Oncology|1989|891Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials|The Lancet|2001|870Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).Ron H.J. Mathijssen, R J van Alphen, Jaco J. Verweij et al.|PubMed|2001|752